Publications by authors named "Vivienne Clark"

Background: Metachromatic Leukodystrophy (MLD) is a rare, autosomal recessive lysosomal storage disease characterised by the progressive loss of motor function and severe decline in cognitive function. Limited information is available on the burden MLD places on patients and their families and the medical and social support these patients need. Three UK-based MLD patient organisations commissioned an online survey, and follow-up semi-structured interviews to describe and quantify these burdens across MLD subtypes, stage of disease (including end of life) and treatment status (untreated, gene therapy or hematopoietic stem cell transplant [HSCT]).

View Article and Find Full Text PDF
Article Synopsis
  • Metachromatic Leukodystrophy (MLD) is a genetic disorder causing progressive motor and cognitive decline due to a deficiency of the ARSA enzyme, leading to early death.
  • An online survey and interviews were conducted with MLD patients and caregivers to explore the significance of early diagnosis and the potential inclusion of MLD in newborn screening (NBS) in the UK.
  • Findings revealed diagnostic delays averaging 1 year, severe deterioration during this time, and overwhelming support among caregivers for NBS, with 95% deeming it crucial for better outcomes for their children.
View Article and Find Full Text PDF

The increasing prevalence of wound infections caused by antibiotic resistant bacteria is an urgent challenge facing modern medicine. To address this issue the expedient use of antimicrobial metals such as zinc, copper and silver were incorporated into an FDA-approved polymer (polycaprolactone - PCL) to produce filaments for 3D printing. These metals have broad-spectrum antimicrobial properties, and moreover, copper and zinc can enhance the wound healing process.

View Article and Find Full Text PDF